In our study, we found that CE significantly inhibits the expression of key rate-limiting enzymes (HMGCS1, HMGCR, IDI1, FDFT1, and SQLE), thereby reducing cholesterol synthesis in SCLC cells. The gene discussed is SQLE; the disease is small cell lung carcinoma.